Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.42 |
| ▸ | RAB9A | P51151 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | POLB | P06746 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
| ▸ | LTA4H | P09960 | 1/20 | 0.30 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL74868 | 0.96 | NPC1 (0.41) | NPC1RAB9AKDM4EALDH1A1POLB | |
| SCHEMBL5164267 | 0.95 | NPC1 (0.40) | NPC1RAB9AKDM4EALDH1A1POLB | |
| SCHEMBL30112936 | 0.92 | KDM4E (0.46) | NPC1RAB9AKDM4EALDH1A1POLB | |
| SCHEMBL342550 | 0.92 | KDM4E (0.46) | NPC1RAB9AKDM4EALDH1A1POLB | |
| SCHEMBL74838 | 0.87 | NPC1 (0.41) | NPC1RAB9AKDM4EALDH1A1POLB | |
| SCHEMBL74867 | 0.87 | NPC1 (0.33) | NPC1RAB9AKDM4EALDH1A1POLB | |
| SCHEMBL74862 | 0.86 | NPC1 (0.35) | NPC1RAB9AKDM4EHPGDALOX15 | |
| SCHEMBL75918 | 0.86 | NPC1 (0.46) | NPC1RAB9AKDM4EALDH1A1POLB | |
| SCHEMBL456993 | 0.86 | NPC1 (0.42) | NPC1RAB9AKDM4EALDH1A1POLB | |
| SCHEMBL30298106 | 0.86 | NPC1 (0.42) | NPC1RAB9AKDM4EALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0855393-B1 | BISBENZOTRIAZOLYLPHENOLS | OTSUKA KAGAKU KK (JP) | 2002-08-14 | — | — | EP | claimed |
| US-11884790-B2 | Near-infrared shielding ultrafine particle dispersion body, near-infrared shielding intermediate film, near-infrared shielding laminated structure, and method for producing near-infrared shielding ultrafine particle dispersion body | SUMITOMO METAL MINING CO., LTD. (JP) | 2024-01-30 | — | — | US | disclosed |
| CN-110662817-B | Near-infrared-shielding ultrafine particle dispersion, near-infrared-shielding intermediate film, near-infrared-shielding sandwich structure, and method for producing near-infrared-shielding ultrafine particle dispersion | 住友金属矿山株式会社 | 2023-02-17 | — | — | CN | disclosed |
| US-20200270401-A1 | NEAR-INFRARED SHIELDING ULTRAFINE PARTICLE DISPERSION BODY, NEAR-INFRARED SHIELDING INTERMEDIATE FILM, NEAR-INFRARED SHIELDING LAMINATED STRUCTURE, AND METHOD FOR PRODUCING NEAR-INFRARED SHIELDING ULTRAFINE PARTICLE DISPERSION BODY | SUMITOMO METAL MINING CO., LTD. (JP) | 2020-08-27 | — | — | US | disclosed |
| EP-3647388-A1 | NEAR-INFRARED-SHIELDING ULTRAFINE PARTICLE DISPERSION BODY, NEAR-INFRARED-SHIELDING INTERMEDIATE FILM, NEAR-INFRARED-SHIELDING LAMINATED STRUCTURE, AND PRODUCTION METHOD FOR NEAR-INFRARED-SHIELDING ULTRAFINE PARTICLE DISPERSION BODY | Sumitomo Metal Mining Co., Ltd. (JP) | 2020-05-06 | — | — | EP | disclosed |
| EP-3255072-B1 | USE OF CURABLE RESIN COMPOSITION FOR HARD COAT, CURED PRODUCT, AND LAMINATE | MITSUBISHI GAS CHEMICAL CO (JP) | 2020-04-29 | — | — | EP | disclosed |
| US-10562996-B2 | Curable resin composition, cured product, and laminate | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2020-02-18 | — | — | US | disclosed |
| EP-2511958-B1 | SEALING FILM FOR SOLAR BATTERY | ADEKA CORP (JP) | 2018-10-10 | — | — | EP | disclosed |
| US-20180022849-A1 | CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2018-01-25 | — | — | US | disclosed |
| US-20170253726-A1 | ENCAPSULANT COMPOSITION FOR SOLAR CELL, SOLAR CELL ENCAPSULANT LAYER PRODUCED THEREWITH, AND SOLAR CELL MODULE PRODUCED THEREWITH | NITTO DENKO CORPORATION (JP) | 2017-09-07 | — | — | US | disclosed |
| EP-2216828-A1 | SEALING FILM FOR SOLAR CELL AND SOLAR CELL USING THE SAME | Bridgestone Corporation (JP) | 2010-08-11 | — | — | EP | disclosed |
| US-6703139-B1 | BISBENZOTRIAZOLYLPHENOL COMPOUND AS AN ULTRAVIOLET ABSORBER | OTSUKA CHEMICAL CO., LTD. (JP) | 2004-03-09 | — | — | US | disclosed |
| US-6703522-B2 | TREATING NEUROLOGICAL CONDITIONS LIKE EPILEPSY AND PAIN | WARNER-LAMBERT COMPANY | 2004-03-09 | — | — | US | disclosed |
| US-20030144214-A1 | Treating neurological conditions like epilepsy and pain | UPJOHN US 1 LLC | 2003-07-31 | — | — | US | disclosed |
| EP-0855393-B1 | BISBENZOTRIAZOLYLPHENOLS | OTSUKA KAGAKU KK (JP) | 2002-08-14 | — | — | EP | disclosed |
| US-20020099092-A1 | Alkyl amino acid derivatives useful as pharmaceutical agents | PARKE-DAVIS & CO. LIMITED (GB) | 2002-07-25 | — | — | US | disclosed |
| EP-1178034-A1 | Alkyl amino acid derivatives useful as pharmaceutical agents | WARNER-LAMBERT COMPANY (US) | 2002-02-06 | — | — | EP | disclosed |
| EP-1104790-A1 | WEATHER-RESISTANT COMPOSITION, COATING MATERIALS AND MOLDED ARTICLES | OTSUKA CHEMICAL COMPANY, LIMITED (JP) | 2001-06-06 | — | — | EP | disclosed |
| US-5922882-A | ULTRAVIOLET RADIATION ABSORBER; COPOLYMERIZATION COMPONENT OF BISBENZOTRIAZOLE COMPRISING A COPOLYCARBONATE, A COPOLYESTER, A COPOLYURETHANE AND A COPOLYURETHANEURA | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1999-07-13 | — | — | US | disclosed |
| EP-0855393-A1 | BISBENZOTRIAZOLYLPHENOLS | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1998-07-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020099092-A1 | Alkyl amino acid derivatives useful as pharmaceutical agents | GABRA6, GABARAPL1, GABRB1 | NPC1 2288/4885RAB9A 847/4885KDM4E 784/4885 |
| US-20030144214-A1 | Treating neurological conditions like epilepsy and pain | GABRB1, GABARAPL1, GABRB3 | NPC1 1787/4885RAB9A 929/4885KDM4E 898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.